Despite the looming finalization of a major policy change, this week’s fiscal year 2025 budget request would freeze the budget [...] …
Articles by : Rich Daly, Editor in Chief
A national hospital advocacy group “insists” multiple television stations remove a dark money group’s political ads alleging federal funding for [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Massachusetts will soon change its Medicaid payment policy to bar managed care plans from paying for seven high-cost, anti-obesity medications [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drugmaker Genentech announced multi-year refunds to 340B providers on past purchases of two separate high-selling drugs, while Merck offered a [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The Centers for Medicare & Medicaid Services (CMS) will direct Medicare administrative contractors (MACs) to provide some accelerated payments to [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Building America’s Future, a nonprofit advocacy group that previously focused on trade, infrastructure, and tobacco issues, recently pushed into drug [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drugmaker Liquidia will implement contract pharmacy restrictions for a single drug that has a still-pending new drug application (NDA). The [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
After missing its self-imposed deadline of publishing the 340B administrative dispute resolution final rule by the end of 2023, the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
After implementing its first contract pharmacy restrictions in January, Japanese pharmaceutical giant Takeda recently subjected another drug to conditions on [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Biopharmaceutical manufacturer Amgen recently expanded its conditions on 340B pricing at contract pharmacies to include grantees. The Thousand Oaks, California-based [...] …